317 related articles for article (PubMed ID: 19223938)
21. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
22. Determination of the genotype and phenotype of serum paraoxonase 1 (PON1) status in a group of agricultural and nonagricultural workers in the Coquimbo Region, Chile.
Zúñiga-Venegas L; Aquea G; Taborda M; Bernal G; Pancetti F
J Toxicol Environ Health A; 2015; 78(6):357-68. PubMed ID: 25734763
[TBL] [Abstract][Full Text] [Related]
23. Effects of occupational exposure to chlorpyrifos on neuropsychological function: a prospective longitudinal study.
Berent S; Giordani B; Albers JW; Garabrant DH; Cohen SS; Garrison RP; Richardson RJ
Neurotoxicology; 2014 Mar; 41():44-53. PubMed ID: 24447827
[TBL] [Abstract][Full Text] [Related]
24. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population.
Cataño HC; Cueva JL; Cardenas AM; Izaguirre V; Zavaleta AI; Carranza E; Hernández AF
Environ Mol Mutagen; 2006 Dec; 47(9):699-706. PubMed ID: 17078098
[TBL] [Abstract][Full Text] [Related]
25. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
[TBL] [Abstract][Full Text] [Related]
26. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
27. Interaction between organophosphate pesticide exposure and PON1 activity on thyroid function.
Lacasaña M; López-Flores I; Rodríguez-Barranco M; Aguilar-Garduño C; Blanco-Muñoz J; Pérez-Méndez O; Gamboa R; Gonzalez-Alzaga B; Bassol S; Cebrian ME
Toxicol Appl Pharmacol; 2010 Nov; 249(1):16-24. PubMed ID: 20691716
[TBL] [Abstract][Full Text] [Related]
28. Paraoxonase 1 (PON1) status and substrate hydrolysis.
Richter RJ; Jarvik GP; Furlong CE
Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
[TBL] [Abstract][Full Text] [Related]
29. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
30. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
31. Chlorpyrifos exposure and biological monitoring among manufacturing workers.
Burns CJ; Garabrant D; Albers JW; Berent S; Giordani B; Haidar S; Garrison R; Richardson RJ
Occup Environ Med; 2006 Mar; 63(3):218-20. PubMed ID: 16497866
[TBL] [Abstract][Full Text] [Related]
32. Dietary exposure to chlorpyrifos and levels of 3,5,6-trichloro-2-pyridinol in urine.
MacIntosh DL; Kabiru C; Echols SL; Ryan PB
J Expo Anal Environ Epidemiol; 2001; 11(4):279-85. PubMed ID: 11571607
[TBL] [Abstract][Full Text] [Related]
33. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
34. Activity and determinants of cholinesterases and paraoxonase-1 in blood of workers exposed to non-cholinesterase inhibiting pesticides.
Lozano-Paniagua D; Gómez-Martín A; Gil F; Parrón T; Alarcón R; Requena M; Lacasaña M; Hernández AF
Chem Biol Interact; 2016 Nov; 259(Pt B):160-167. PubMed ID: 27062891
[TBL] [Abstract][Full Text] [Related]
35. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
36. Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.
Furlong CE; Cole TB; Jarvik GP; Pettan-Brewer C; Geiss GK; Richter RJ; Shih DM; Tward AD; Lusis AJ; Costa LG
Neurotoxicology; 2005 Aug; 26(4):651-9. PubMed ID: 16112327
[TBL] [Abstract][Full Text] [Related]
37. Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.
Coombes RH; Meek EC; Dail MB; Chambers HW; Chambers JE
Toxicol Lett; 2014 Oct; 230(1):57-61. PubMed ID: 25093614
[TBL] [Abstract][Full Text] [Related]
38. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
Furlong CE
J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
[TBL] [Abstract][Full Text] [Related]
39. Effects of Paraoxonase 1 gene polymorphisms on organophosphate insecticide metabolism in Japanese pest control workers.
Sato H; Ito Y; Ueyama J; Kano Y; Arakawa T; Gotoh M; Kondo T; Sugiura Y; Saito I; Shibata E; Kamijima M
J Occup Health; 2016; 58(1):56-65. PubMed ID: 26549836
[TBL] [Abstract][Full Text] [Related]
40. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
Li WF; Costa LG; Furlong CE
J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
